Treatment

Displaying 1 - 10 of 60

Non-invasive VNS cleared for episodic cluster headaches

Non-invasive VNS cleared for episodic cluster headaches
electroCore has announced that the U.S. FDA released the use of gammaCore (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore transmits a mild electrical stimulation to the vagus nerve through the skin, resulting in a reduction of pain. This is the first FDA product release for electroCore in the U.S.
20th April 2017

Digital inhaler add-on offers slick aid to asthma care

Digital inhaler add-on offers slick aid to asthma care
  What do you get by marrying an asthma inhaler to a wireless monitor and a smartphone app? Plenty, says David Van Sickle, a medical anthropologist who specialises in respiratory disease. In 2011, Van Sickle created a spinoff called Propeller Health while he was working on respiratory disease prevention at UW Health in Madison.
20th April 2017

Vision sensor reliably reads pharmacodes

Vision sensor reliably reads pharmacodes
EVT presents a new vision sensor for reading pharmacodes also known as Pharmaceutical Binary Code: the EyeSens PharmaCode Reader (PCR). The pharmacode is a 7-digit numerical code for an unambiguous identification of pharmaceutical specialities and other products. The pharmacode can represent only a single integer from 3 to 131070.
20th April 2017


Portable Positive Airway Pressure system can be used anywhere

Portable Positive Airway Pressure system can be used anywhere
Royal Philips has announced the launch of DreamStation Go, its newest and smallest positive airway pressure (PAP) device designed to simplify travel for patients living with obstructive sleep apnea (OSA). At half the size of Philips’ previous generation devices, DreamStation Go delivers the same clinically-proven performance and comfort, for reliable, convenient therapy on-the-go.
19th April 2017

Research focuses on nasal drug delivery into brain

Research focuses on nasal drug delivery into brain
Delivering life-saving drugs directly to the brain in a safe and effective way is a challenge for medical providers. One key reason: the blood-brain barrier, which protects the brain from tissue-specific drug delivery. Methods such as an injection or a pill aren’t as precise or immediate as doctors might prefer, and ensuring delivery right to the brain often requires invasive, risky techniques.
19th April 2017

Portable respiratory system integrates functions in single device

Portable respiratory system integrates functions in single device
Ventec Life Systems has announced it received 510(k) clearance from the U.S. FDA for VOCSN, the only portable life support device to combine five respiratory therapies - Ventilation, Oxygen, Cough, Suction, and Nebulisation (VOCSN, pronounced VOX-SEN). VOCSN works across the continuum of care, from the hospital to home, and for pediatric patients weighing more than 5 kg to adults.
19th April 2017

Spinal cord stimulation helps man move paralysed legs

Spinal cord stimulation helps man move paralysed legs
  Mayo Clinic researchers used electrical stimulation on the spinal cord and intense physical therapy to help a man intentionally move his paralysed legs, stand and make steplike motions for the first time in three years. The case, the result of collaboration with UCLA researchers, appears in Mayo Clinic Proceedings.
6th April 2017

Bioresorbable coronary scaffold has been cleared in Europe

Bioresorbable coronary scaffold has been cleared in Europe
REVA Medical, a San Diego, California firm, has landed the European CE Mark for its first product, the drug-eluting bioresorbable Fantom coronary scaffold. The device contains sirolimus, aka rapamycin, an immunosuppressant to help prevent restenosis, which is delivered to the implantation area slowly over time. The device itself eventually breaks up and is resorbed by the body.
6th April 2017

Developing dual vaccine against yellow fever and rabies

Developing dual vaccine against yellow fever and rabies
Rabies and yellow fever claim ten thousands of lives each year. Vaccines already exist but various drawbacks that hinder their efficient distribution. One of them is the need to transport and store these vaccines at cool temperatures. The RABYD-VAX consortium, led by KU Leuven, has now set out to develop a cheap, temperature-stable, and easy-to-produce vaccine against both diseases at once.
6th April 2017

A breakthrough in the fight against female reproductive disease

A breakthrough in the fight against female reproductive disease
Northwestern Medicine has developed a miniature female reproductive tract that fits in the palm of your hand and could eventually change the future of research and treatment of diseases in women's reproductive organs. This 3D technology - called EVATAR - is made with human tissue and will enable scientists to conduct much-needed testing of new drugs for safety and effectiveness on the female reproductive system.
28th March 2017


Treatment documents

Datasheets
Whitepapers

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

LASER World of PHOTONICS 2017
26th June 2017
Germany Messe Munchen